Thomas Rachel L, Mistry Rajendra, Langmead Christopher J, Wood Martyn D, Challiss R A John
Department of Cell Physiology and Pharmacology, University of Leicester, Room 4/04, Henry Wellcome Building, Lancaster Road, Leicester LE19HN, UK.
J Pharmacol Exp Ther. 2008 Nov;327(2):365-74. doi: 10.1124/jpet.108.141788. Epub 2008 Jul 29.
The M(1) muscarinic acetylcholine (mACh) receptor is among a growing number of G protein-coupled receptors that are able to activate multiple signaling cascades. AC-42 (4-n-butyl-1-[4-(2-methylphenyl)-4-oxo-1-butyl] piperidine) is an allosteric agonist that can selectively activate the M(1) mACh receptor in the absence of an orthosteric ligand. Allosteric agonists have the potential to stabilize unique receptor conformations, which may in turn cause differential activation of signal transduction pathways. In the present study, we have investigated the signaling pathways activated by AC-42, its analog 77-LH-28-1 (1-[3-(4-butyl-1-piperidinyl)propyl]-3,4-dihydro-2(1H)-quinolinone), and a range of orthosteric muscarinic agonists [oxotremorine-M (oxo-M), arecoline, and pilocarpine] in Chinese hamster ovary cells recombinantly expressing the human M(1) mACh receptor. Each agonist was able to activate Galpha(q/11)-dependent signaling, as demonstrated by an increase in guanosine 5'-O-(3-thiotriphosphate) ([(35)S]GTPgammaS) binding to Galpha(q/11) proteins and total [(3)H]inositol phosphate accumulation assays in intact cells. All three orthosteric agonists caused significant enhancements in [(35)S]GTPgammaS binding to Galpha(i1/2) subunits over basal; however, neither allosteric ligand produced a significant response. In contrast, both orthosteric and allosteric agonists are able to couple to the Galpha(s)/cAMP pathway, enhancing forskolin-stimulated cAMP accumulation. These data provide support for the concept that allosteric and orthosteric mACh receptor agonists both stabilize receptor conformations associated with Galpha(q/11)- and Galpha(s)-dependent signaling; however, AC-42 and 77-LH-28-1, unlike oxo-M, arecoline, and pilocarpine, do not seem to promote M(1) mACh receptor-Galpha(i1/2) coupling, suggesting that allosteric agonists have the potential to activate distinct subsets of downstream effectors.
毒蕈碱型乙酰胆碱(mACh)M(1)受体属于越来越多能够激活多种信号级联反应的G蛋白偶联受体。AC-42(4-正丁基-1-[4-(2-甲基苯基)-4-氧代-1-丁基]哌啶)是一种变构激动剂,在没有正构配体的情况下能够选择性激活M(1) mACh受体。变构激动剂有可能稳定独特的受体构象,这反过来可能导致信号转导途径的差异激活。在本研究中,我们研究了AC-42、其类似物77-LH-28-1(1-[3-(4-丁基-1-哌啶基)丙基]-3,4-二氢-2(1H)-喹啉酮)以及一系列正构毒蕈碱激动剂[氧化震颤素-M(oxo-M)、槟榔碱和毛果芸香碱]在中国仓鼠卵巢细胞中重组表达人M(1) mACh受体时所激活的信号通路。如完整细胞中鸟苷5'-O-(3-硫代三磷酸)([(35)S]GTPγS)与Gα(q/11)蛋白结合增加以及总[(3)H]肌醇磷酸积累测定所证明的,每种激动剂都能够激活Gα(q/11)依赖性信号传导。所有三种正构激动剂均使[(35)S]GTPγS与Gα(i1/2)亚基的结合相对于基础水平显著增强;然而,两种变构配体均未产生显著反应。相反,正构和变构激动剂均能够与Gα(s)/cAMP途径偶联,增强福斯可林刺激的cAMP积累。这些数据支持了变构和正构mACh受体激动剂均能稳定与Gα(q/11)和Gα(s)依赖性信号传导相关的受体构象这一概念;然而,与oxo-M、槟榔碱和毛果芸香碱不同,AC-42和77-LH-28-1似乎不会促进M(1) mACh受体与Gα(i1/2)的偶联,这表明变构激动剂有可能激活不同的下游效应子亚群。